Results

Total Results: 1,534 records

Showing results for "drug".

261. Analysis of Patient Safety: Converting Complex Pediatric Chemotherapy Ordering Processes from Paper to Electronic Systems (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol2/Advances-Baker_107.pdf
     March 30, 2008 - provider order entry, CPOE) has been touted as a key method to reduce medication errors and adverse drug … the pharmacy information system (Cerner Inpatient PharmNet®), which provides automated allergy and drug … often occurs prior to patient arrival and receipt of the patient’s medical record; (2) receipt of the drug … pharmacy are compared against the orders and electronic medication administration record entries for drug … staff not recognizing premedications that were indicated but not ordered based upon previous adverse drug

262. 2017Qdr-Patsafchartbook (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/chartbooks/patientsafety/2017qdr-patsafchartbook.pdf
     October 01, 2018 - event to warfarin (Adverse drug events) …  Adverse drug events. … Adverse Drug Events • An adverse drug event (ADE) is an injury—including physical harm, mental harm, … or loss of function—resulting from medical intervention involving a drug … Adverse Drug Events With Warfarin Adult hospital patients with an anticoagulant-related adverse drug

263. Preventing Medication Errors Among Children With Chronic Conditions in Outpatient and Home Settings | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/funding/grantee-profiles/grtprofile-walsh.html
     October 01, 2023 - Walsh is working to prevent medication errors and adverse drug events among children, particularly those … Her team found that 10 percent of children with leukemia or lymphoma experienced adverse drug events

264. The “Usually Antibiotics” Diagnoses: Community-Acquired Pneumonia – Slides
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/ambulatory-care/cap-slides.pptx
     September 01, 2022 - FDA Drug Safety Communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics … Food and Drug Administration. … Mar 8, 2018. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-updates-warnings-oral-and-injectable-fluoroquinolone-antibiotics

265. Improving Patient Safety Using ATHENA-Decision Support System Technology: The Opioid Therapy for Chronic Pain Experience (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol4/Advances-Michel_92.pdf
     April 30, 2008 - These systems can highlight absolute and relative contraindications to drug therapy; alert about the … • Patients with suggestive laboratory results (e.g., positive drug screens for cocaine or opioids … Tools include a structured pain assessment, instructions for conducting urine drug screens and making … Drug Alcohol Depend 2001; 64: 233-241. 13. Regier DA, Farmer ME, Rae DS, et al. … Comorbidity of mental disorders with alcohol and other drug abuse.

266. 2023 National Healthcare Quality and Disparities Report | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/research/findings/nhqrdr/nhqdr23/app-b.html
     December 01, 2023 - The data collection for the 2020 National Survey on Drug Use and Health and 2020 National Health Interview … NSDUH = National Survey on Drug Use and Health.

267. CHIPRA 213: Section 5, Table 4 (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-213-section-5-table-4.pdf
     January 01, 2012 - Lancet of renal and spleen function, subjects receiving 2011; 377(9778): 1663‐ the drug had few episodes … selected children and adolescents, accompanied by frequent monitoring for myelotoxicity and other drug … The drug should be considered for young patients with young patients with few acute clinical events

268. Strategies to Improve Communication Between Pharmacy Staff and Patients: A Training Program for Pharmacy Staff (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/pharmhealthlit/pharmlit/pharmtrain.pdf
     January 01, 2010 - Now, let’s review some important health communication messages about drug warnings and patient safety … 29% correct Medication adherence Adverse drug events (?) Health care costs Fang et al 2006. … • Anecdotal evidence of making mistakes with their medications and experiencing more adverse drug … Low Literacy Impairs Comprehension of Prescription Drug Warning Labels. … Low Literacy Impairs Comprehension of Prescription Drug Warning Labels.

269. Section 2, Table 1, Technical Specifications and Scoring for Caregiver Survey (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-166-fecc-table-1-tech-specs.pdf
     March 09, 2018 - Mean of rescaled Q18b and Q18c care IE2c Drug … hospital, got written hospital stay summary at discharge) Q18d (list of “child’s allergies”, not drug … Mean of rescaled Q23b and Q23c IE5c Drug … to look up information about child’s visits and care) Q23d (list of “child’s allergies”, not drug

270. AHRQ Views: New Guide Helps Developers and Users of Digital Healthcare Technologies Advance Equity | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/news/newsletters/e-newsletter/909.html
     April 01, 2024 - Drug-drug interactions and actual harm to hospitalized patients: a multicentre study examining the prevalence … Pharmacoepidemiol Drug Saf 2024 Apr;33(4):e5777. Access the abstract on PubMed®.

271. Tennessee Hospital Association Uses AHRQ Tools To Boost Patient Safety, Saving $17 Million | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/news/newsroom/case-studies/201702.html
     March 01, 2017 - Among others, these safety challenges included: Adverse drug events. … Safety Organization (PSO), Re-Engineered Discharge (RED) Topic(s): Adverse Drug

272. Action-Plan-Form (doc file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/health-literacy/3rd-edition-toolkit/action-plan-form.docx
     March 01, 2024 - Action Plan Form My visit with: Date: What I want to do for my health: |_| Eat better |_| Be more active |_| Manage my stress |_| Handle my feelings better |_| Sleep better |_| Take my medicine Cut down or stop: |_| smoking |_| drinking |_| drugs |_| Something else: Goal – One …

273. Final Progress Report: Medications at Transitions and Clinical Handoffs (MATCH) (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/2024-01/noskin-report.pdf
     January 01, 2024 - Excluding vitamins and supplements, cardiovascular agents were the most common discrepant drug class … Key Words: medication reconciliation, medication errors, adverse drug events, health literacy, medication … a medication history only 5% of the time,23 despite findings of one study showing that over 70% of drug … gastrointestinal (GI) agents (14.2%), nonopiates (5.9%), and anti-diabetic agents (5.7%) were the top four drug … Incidence of adverse drug events and potential adverse drug events: implications for prevention.

274. Draft Final Report Estimating the Additional Hospital Inpatient Cost and Mortality Associated with Selected Hospital Acquired Conditions (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/pfp/hac-cost-report2017.pdf
     November 01, 2017 - Adverse Drug Events (anticoagulants, opioids, and hypoglycemic agents) 2. … events involving other drug classes. … Events ((“Drug therapy/adverse effects”[mh] OR “drug interactions”[mh] OR “anaphylaxis”[mh] OR “drug … overdose”[mh] OR “Drug-related side effects and adverse reactions”[mh] OR “adverse drug event”[tiab … ] OR “adverse drug events”[tiab] OR “adverse drug reaction”[tiab] OR “adverse drug reactions”[tiab]

275. Technical Specifications for Timely Fluid Bolus for Children With Severe Sepsis or Septic Shock (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0231-technical-specifications.pdf
     April 26, 2018 - hypotension) < 5th percentile for age or systolic BP < 2 SD below normal for age OR • Need for vasoactive drug

276. Action Alliance Background Materials | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/action-alliance/background/index.html
     October 01, 2023 - Operating Officer Jonathan Blum  (PDF, 108 KB) Robert Califf , Commissioner of Food and Drugs, Food and Drug

277. AHRQ Six Building Blocks: A Team-Based Approach to Improving Opioid Management in Primary Care | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/patient-safety/settings/ambulatory/improve/six-building-blocks.html
     March 01, 2022 - Blocks: A Team-Based Approach to Improving Opioid Management in Primary Care Deaths from drug … support for the 6BBs program came from the Washington State Department of Health, National Institute on Drug

278. Making Healthcare Safer III | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/research/findings/making-healthcare-safer/mhs3/index.html
     April 01, 2020 - Harms such as adverse drug events, healthcare-associated infections (HAIs), falls, and obstetric adverse … Harms Due to Anticoagulants (PDF, 2 MB) Harms Due to Diabetic Agents (PDF, 1.6 MB) Reducing Adverse Drug

279. Figure 11: Comparison of Audit Techniques | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/patient-safety/settings/hospital/match/figure-11.html
     July 01, 2022 - Tracks the type of discrepancies, number of interventions, drug/drug class involved, harm averted, etc

280. Medication: Safety | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/topics/medication-safety.html
     offers patient education materials for healthcare professionals to reduce risks related to adverse drug